Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma.
Jasielec JK, Kubicki T, Raje N, Vij R, Reece D, Berdeja J, Derman BA, Rosenbaum CA, Richardson P, Gurbuxani S, Major S, Wolfe B, Stefka AT, Stephens L, Tinari KM, Hycner T, Rojek AE, Dytfeld D, Griffith KA, Zimmerman TM, Jakubowiak AJ. Jasielec JK, et al. Among authors: gurbuxani s. Blood. 2020 Nov 26;136(22):2513-2523. doi: 10.1182/blood.2020007522. Blood. 2020. PMID: 32735641 Free PMC article. Clinical Trial.
Red cell morphology in sickle cell disease.
Parilla M, Gurbuxani S. Parilla M, et al. Among authors: gurbuxani s. Blood. 2020 Oct 15;136(16):1893. doi: 10.1182/blood.2020007602. Blood. 2020. PMID: 33057703 Free article. No abstract available.
CXCL4's "Gliful" subversion of BM in MPN.
Gurbuxani S. Gurbuxani S. Blood. 2020 Oct 29;136(18):1999-2000. doi: 10.1182/blood.2020007943. Blood. 2020. PMID: 33119760 Free article. No abstract available.
bcr3 PML-RARA: short fusion, small blasts!
Takeda MR, Gurbuxani S. Takeda MR, et al. Among authors: gurbuxani s. Blood. 2021 May 13;137(19):2708. doi: 10.1182/blood.2021010965. Blood. 2021. PMID: 33983418 Free PMC article. No abstract available.
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study.
Derman BA, Kansagra A, Zonder J, Stefka AT, Grinblatt DL, Anderson LD Jr, Gurbuxani S, Narula S, Rayani S, Major A, Kin A, Jiang K, Karrison T, Jasielec J, Jakubowiak AJ. Derman BA, et al. Among authors: gurbuxani s. JAMA Oncol. 2022 Sep 1;8(9):1278-1286. doi: 10.1001/jamaoncol.2022.2424. JAMA Oncol. 2022. PMID: 35862034 Free PMC article. Clinical Trial.
114 results